Literature DB >> 11309260

Selective inhibition of human inducible nitric oxide synthase by S-alkyl-L-isothiocitrulline-containing dipeptides.

J M Park1, T Higuchi, K Kikuchi, Y Urano, H Hori, T Nishino, J Aoki, K Inoue, T Nagano.   

Abstract

The aim of this study was to investigate the structure-activity relationship of S-alkyl-L-isothiocitrulline-containing dipeptides towards three partially purified recombinant human nitric oxide synthase (NOS) isozymes, as well as the effects of these compounds on cytokine-induced NO production by human DLD-1 cells. In an in vitro assay, S-methyl-L-isothiocitrulline (L-MIT) was slightly selective for human neuronal NOS (nNOS) over the inducible (iNOS) or endothelial (eNOS) isozyme, but the combination of a hydrophobic L-amino acid (L-Phe, L-Leu or L-Trp) with L-MIT dramatically altered the inhibition pattern to give selective iNOS inhibitors. Introduction of a hydroxy, nitro, amino or methoxy group at the para position of the aromatic ring of L-MIT-L-Phe (MILF) decreased the selectivity and inhibitory potency. A longer or larger S-alkyl group also decreased the selectivity and potency. Dixon analysis showed that all of the dipeptides were competitive inhibitors of the three isoforms of human NOS. The enzymatic time course curves indicated that MILF was a slow binding inhibitor of human iNOS. These results suggest that the human NOS isozymes have different-sized cavities in the binding site near the position to which the C-terminal of L-arginine binds, and the cavity of iNOS is hydrophobic. Interestingly, L-MIT-D-Phe (MIDF) showed little inhibitory activity or selectivity, suggesting that the cavity of human iNOS is located in a well-defined direction from the alpha carbon atom. NO production in cytokine-stimulated human DLD-1 cells was measured with a fluorescent indicator, DAF-FM. MILF, L-MIT-L-Trp(-CHO) (MILW) and L-MIT-L-Tyr (MILY) showed more potent activity than L-MIT in this whole-cell assay. Thus, S-alkyl-L-isothiocitrulline-containing dipeptides are selective inhibitors of human iNOS, and work efficiently in cell-based assay.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11309260      PMCID: PMC1572740          DOI: 10.1038/sj.bjp.0704023

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  30 in total

1.  The determination of enzyme inhibitor constants.

Authors:  M DIXON
Journal:  Biochem J       Date:  1953-08       Impact factor: 3.857

Review 2.  Nitric oxide synthases: roles, tolls, and controls.

Authors:  C Nathan; Q W Xie
Journal:  Cell       Date:  1994-09-23       Impact factor: 41.582

3.  Purification and cDNA sequence of an inducible nitric oxide synthase from a human tumor cell line.

Authors:  P A Sherman; V E Laubach; B R Reep; E R Wood
Journal:  Biochemistry       Date:  1993-11-02       Impact factor: 3.162

4.  The inducible production of nitric oxide by articular cell types.

Authors:  J J Rediske; C F Koehne; B Zhang; M Lotz
Journal:  Osteoarthritis Cartilage       Date:  1994-09       Impact factor: 6.576

5.  Cytokine-activated endothelial cells express an isotype of nitric oxide synthase which is tetrahydrobiopterin-dependent, calmodulin-independent and inhibited by arginine analogs with a rank-order of potency characteristic of activated macrophages.

Authors:  S S Gross; E A Jaffe; R Levi; R G Kilbourn
Journal:  Biochem Biophys Res Commun       Date:  1991-08-15       Impact factor: 3.575

6.  Nitric oxide production and inducible nitric oxide synthase expression in inflammatory arthritides.

Authors:  H Sakurai; H Kohsaka; M F Liu; H Higashiyama; Y Hirata; K Kanno; I Saito; N Miyasaka
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808

7.  Quantitation of nitrotyrosine levels in lung sections of patients and animals with acute lung injury.

Authors:  I Y Haddad; G Pataki; P Hu; C Galliani; J S Beckman; S Matalon
Journal:  J Clin Invest       Date:  1994-12       Impact factor: 14.808

8.  Tyrosine kinase involvement in IL-1 beta-induced expression of iNOS by beta-cells purified from islets of Langerhans.

Authors:  J A Corbett; G Kwon; T P Misko; C P Rodi; M L McDaniel
Journal:  Am J Physiol       Date:  1994-07

9.  Functional expression of three isoforms of human nitric oxide synthase in baculovirus-infected insect cells.

Authors:  M Nakane; J S Pollock; V Klinghofer; F Basha; P A Marsden; A Hokari; T Ogura; H Esumi; G W Carter
Journal:  Biochem Biophys Res Commun       Date:  1995-01-17       Impact factor: 3.575

10.  Beneficial effects and improved survival in rodent models of septic shock with S-methylisothiourea sulfate, a potent and selective inhibitor of inducible nitric oxide synthase.

Authors:  C Szabó; G J Southan; C Thiemermann
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-20       Impact factor: 11.205

View more
  4 in total

Review 1.  Nitric oxide synthase and structure-based inhibitor design.

Authors:  Thomas L Poulos; Huiying Li
Journal:  Nitric Oxide       Date:  2016-11-23       Impact factor: 4.427

2.  Nitric oxide release follows endothelial nanomechanics and not vice versa.

Authors:  Johannes Fels; Chiara Callies; Kristina Kusche-Vihrog; Hans Oberleithner
Journal:  Pflugers Arch       Date:  2010-09-01       Impact factor: 3.657

Review 3.  Development of nitric oxide synthase inhibitors for neurodegeneration and neuropathic pain.

Authors:  Paramita Mukherjee; Maris A Cinelli; Soosung Kang; Richard B Silverman
Journal:  Chem Soc Rev       Date:  2014-10-07       Impact factor: 54.564

Review 4.  Arginine-based inhibitors of nitric oxide synthase: therapeutic potential and challenges.

Authors:  Jan Víteček; Antonín Lojek; Giuseppe Valacchi; Lukáš Kubala
Journal:  Mediators Inflamm       Date:  2012-09-04       Impact factor: 4.711

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.